Experience
The Aventine PharmD team has over 30 years of combined experience in the areas of managed care, medical writing, and clinical pharmacy practice. We have developed more than 250 dossiers over the past decade.
Oncology
- Acute myeloid leukemia
- Acute lymphocytic leukemia
- Anaplastic large cell lymphoma
- Basal cell carcinomas
- Breast cancers
- Cervical cancer
- Chronic lymphocytic leukemia
- Chronic myeloid leukemia
- Colorectal cancer
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Gastrointestinal stromal tumor
- Glioblastoma
- Head and neck cancers
- Hepatocellular carcinoma
- Hodgkin lymphoma
- Lung cancers
- Melanoma
- Multiple myeloma
- Myelofibrosis
- Non-Hodgkin lymphomas
- Non-small cell lung cancers
- Neuroblastoma
- Neutropenia, chemotherapy-induced
- Ovarian cancer
- Pancreatic cancers
- Peripheral T-cell lymphoma
- Prostate cancer
- Renal cell carcinoma
- Skin cancers
- Soft tissue sarcomas
- Small cell lung cancer
- Urothelial carcinoma
Inflammatory Disease/ Inherited Disease
- Allergic rhinitis
- Alopecia areata
- Alpha1-antitrypsin deficiency
- Asthma
- Atopic dermatitis
- Chronic obstructive pulmonary disease
- Cystic fibrosis
- Hemophilia A
- Huntington’s disease
- Polyarticular juvenile idiopathic arthritis
- Primary immunodeficiencies
- Psoriasis
- Psoriatic arthritis
- Rheumatoid arthritis
- Sickle-cell anemia
- Systemic juvenile idiopathic arthritis
- Systemic lupus erythematosus
- Tardive dyskinesia
Neurology/Central Nervous System
- Abuse-deterrent opioids
- Acute agitation
- Adult upper limb spasticity
- Attention-deficit hyperactivity disorder
- Bipolar disorder
- Cervical dystonia
- Epilepsy
- Insomnia
- Migraine
- Multiple sclerosis
- Neuropathies
- Pain management
- Parkinson’s disease
- Procedural sedation
- Pseudobulbar affect
- Restless legs syndrome
- Schizophrenia
- Tardive dyskinesia
Gastrointestinal/ Renal/ Hepatic
- Anemia
- Chemo-induced nausea and vomiting
- Chronic idiopathic constipation
- Chronic kidney disease
- Crohn’s disease
- Exocrine pancreatic insufficiency
- Hepatitis B
- Hepatitis C
- Hyperphosphatemia
- Irritable bowel syndrome
- Liver transplantation
- Opioid-induced constipation
- Post-operative nausea and vomiting
- Renal transplantation
- Ulcerative colitis
Women’s Health
- Endometriosis
- Hormonal contraception
- Hormone replacement therapy
- Infertility
- Menorrhagia
- Non-hormonal contraception
- Postmenopausal osteoporosis
- Uterine fibroids
- Vulvovaginal atrophy
Infectious Disease/Dermatology
- Acne/rosacea
- Bacterial vaginosis
- Complicated skin infections
- COVID-19 vaccine
- Diabetic neuropathic ulcers
- Head lice
- HIV/AIDS
- Invasive fungal infections
- Neutropenic fever
- Otitis media
- Pneumonia
- Pyelonephritis
- RSV
- Trichomoniasis
- Urinary tract infection (UTI)
- Wound care
Endocrinology/ Cardiovascular Disease
- Cardiac transplant
- Cardiomyopathy
- Central precocious puberty
- Congestive heart failure
- Deep vein thrombosis
- Diabetes mellitus, Type 2
- Growth hormone deficiency
- Hypertension
- Obesity
- Pulmonary arterial hypertension
- Stroke prevention
- Vasodilatory shock
Specific Biotechnologies
- Antibody-drug conjugate technologies
- Biomarker-driven therapies
- Biosimilars
- CAR-T cell therapy
- Checkpoint inhibitors
- Colony stimulating factors
- Digital inhalers
- Enzyme-replacement therapies
- Follow-on biologics
- Immune modulators
- Implantable contraceptive devices
- Monoclonal antibodies
- Respiratory delivery systems
- Sustained-release injectable prodrugs
- Targeted therapies
- Thermosensitive polymers
- Vaccine technology
- Viscosupplements and cartilage repair
Aventine specifically focuses on the development of US formulary submission dossiers, in the latest Academy of Managed Care Pharmacy (AMCP) format, designed to scientifically and effectively demonstrate the value of a product to payers for the purpose of achieving optimal product reimbursement. Our team of highly accomplished PharmDs has years of experience and expertise developing AMCP dossiers for a wide range of products across diverse disease states and clinical settings. Because our team has past experience evaluating products for reimbursement and formulary inclusion from the payer side of the access equation, we understand the needs of the US payer audience and are able to leverage that knowledge in developing dossiers that are fit for purpose. Understanding our payer audience has been a cornerstone to our continued success.